Microbial biomarkers identified in lupus and IBD offer pathways for targeted therapies

A study has identified microbial patterns linked to autoimmune diseases such as inflammatory bowel disease (IBD) and systemic lupus erythematosus (SLE), suggesting the gut microbiome could be a potential target for personalized treatments. The research further stressed the role of gut bacteria in autoimmune illnesses and demonstrated the links between gut composition and disease symptoms. DNA sequencing and protein-protein interactions (PPI) analysis helped predict microbial roles in diseases and offer functional insights into species-level variations, notably in IBD and SLE.